491 related articles for article (PubMed ID: 24504372)
1. Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-κB activation.
Li J; Zhong W; Wang W; Hu S; Yuan J; Zhang B; Hu T; Song G
PLoS One; 2014; 9(2):e87810. PubMed ID: 24504372
[TBL] [Abstract][Full Text] [Related]
2. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
[TBL] [Abstract][Full Text] [Related]
3. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice.
Huang YF; Zhou JT; Qu C; Dou YX; Huang QH; Lin ZX; Xian YF; Xie JH; Xie YL; Lai XP; Su ZR
J Ethnopharmacol; 2017 Feb; 198():389-398. PubMed ID: 28119098
[TBL] [Abstract][Full Text] [Related]
5. Black tea extract prevents lipopolysaccharide-induced NF-κB signaling and attenuates dextran sulfate sodium-induced experimental colitis.
Song YA; Park YL; Kim KY; Chung CY; Lee GH; Cho DH; Ki HS; Park KJ; Cho SB; Lee WS; Kim N; Ahn BW; Joo YE
BMC Complement Altern Med; 2011 Oct; 11():91. PubMed ID: 21989142
[TBL] [Abstract][Full Text] [Related]
6. Activation of the epidermal growth factor receptor in macrophages regulates cytokine production and experimental colitis.
Lu N; Wang L; Cao H; Liu L; Van Kaer L; Washington MK; Rosen MJ; Dubé PE; Wilson KT; Ren X; Hao X; Polk DB; Yan F
J Immunol; 2014 Feb; 192(3):1013-23. PubMed ID: 24391216
[TBL] [Abstract][Full Text] [Related]
7. Monotropein isolated from the roots of Morinda officinalis ameliorates proinflammatory mediators in RAW 264.7 macrophages and dextran sulfate sodium (DSS)-induced colitis via NF-κB inactivation.
Shin JS; Yun KJ; Chung KS; Seo KH; Park HJ; Cho YW; Baek NI; Jang D; Lee KT
Food Chem Toxicol; 2013 Mar; 53():263-71. PubMed ID: 23261679
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxy-4-methoxycanthin-6-one alleviates dextran sodium sulfate-induced colitis in rats via regulation of metabolic profiling and suppression of NF-κB/p65 signaling pathway.
Liu F; Yao Y; Lu Z; Zhang Q; Liu C; Zhu C; Lin C
Phytomedicine; 2021 Feb; 82():153438. PubMed ID: 33422953
[TBL] [Abstract][Full Text] [Related]
9. Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice.
Yan F; Wang L; Shi Y; Cao H; Liu L; Washington MK; Chaturvedi R; Israel DA; Cao H; Wang B; Peek RM; Wilson KT; Polk DB
Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(5):G504-14. PubMed ID: 22173918
[TBL] [Abstract][Full Text] [Related]
10. Canna x generalis L.H. Bailey rhizome extract ameliorates dextran sulfate sodium-induced colitis via modulating intestinal mucosal dysfunction, oxidative stress, inflammation, and TLR4/ NF-ҡB and NLRP3 inflammasome pathways.
Mahmoud TN; El-Maadawy WH; Kandil ZA; Khalil H; El-Fiky NM; El Alfy TSMA
J Ethnopharmacol; 2021 Apr; 269():113670. PubMed ID: 33301917
[TBL] [Abstract][Full Text] [Related]
11. Anti-Colitic Effects of Ethanol Extract of
Hong JY; Chung KS; Shin JS; Park G; Jang YP; Lee KT
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621304
[No Abstract] [Full Text] [Related]
12. Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway.
Fei L; Xu K
J Ethnopharmacol; 2016 Nov; 192():236-247. PubMed ID: 27452656
[TBL] [Abstract][Full Text] [Related]
13. Berberine inhibits macrophage M1 polarization via AKT1/SOCS1/NF-κB signaling pathway to protect against DSS-induced colitis.
Liu Y; Liu X; Hua W; Wei Q; Fang X; Zhao Z; Ge C; Liu C; Chen C; Tao Y; Zhu Y
Int Immunopharmacol; 2018 Apr; 57():121-131. PubMed ID: 29482156
[TBL] [Abstract][Full Text] [Related]
14. Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice.
Chun J; Lee C; Hwang SW; Im JP; Kim JS
Life Sci; 2014 Aug; 110(1):23-34. PubMed ID: 24992474
[TBL] [Abstract][Full Text] [Related]
15. Hydrangenol, an active constituent of
Kim SY; Chung KS; Jang SY; Han HS; Heo SW; Lee JK; Kim HJ; Shin YK; Ahn HS; Lee SH; Lee KT
Food Funct; 2023 Jul; 14(15):6957-6968. PubMed ID: 37435675
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium chloride improves the course of TNBS and DSS-induced colitis through protecting against colonic mucosal inflammation.
Du C; Wang P; Yu Y; Chen F; Liu J; Li Y
Sci Rep; 2014 Aug; 4():6096. PubMed ID: 25146101
[TBL] [Abstract][Full Text] [Related]
17. Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response.
Wang Y; Liu J; Huang Z; Li Y; Liang Y; Luo C; Ni C; Xie J; Su Z; Chen J; Li C
Eur J Pharmacol; 2021 Apr; 896():173912. PubMed ID: 33508280
[TBL] [Abstract][Full Text] [Related]
18. Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-κB and MAPK signaling inactivation.
Dou W; Zhang J; Ren G; Ding L; Sun A; Deng C; Wu X; Wei X; Mani S; Wang Z
Int Immunopharmacol; 2014 Nov; 23(1):170-8. PubMed ID: 25194678
[TBL] [Abstract][Full Text] [Related]
19. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
[TBL] [Abstract][Full Text] [Related]
20. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
